720-777-0123
- Your Visit
-
Research & Innovation
It starts with a Q:
For the latest cutting-edge research, innovative collaborations and remarkable discoveries in child health, read stories from across all our areas of study in Q: Advances and Answers in Pediatric Health.
Pediatric heart diseases are not simply adult heart problems in children. My goals are to help families navigate through this unique world of pediatric heart disease, and expand our understanding of these conditions in order to have effective pediatric-focused treatments for the future.
Get to know Stephanie Nakano, MD
- Cardiomyopathy
- Congenital Heart Defects (CHD)
- Heart Failure
- Hypertrophic Cardiomyopathy
- English
My clinical focus is on the care of children and young adults with decreased heart function (including those with cardiomyopathy, myocarditis, single ventricle congenital heart disease, and following heart transplantation) as well as those with general pediatric cardiology conditions.
Undergraduate 2003
University of California–Los Angeles (CA)
Medical Education 2007
Vanderbilt University School of Medicine
Residency 2010
Children's Hospital-Oakland Program
Fellowship 2014
University of Colorado (Children's Hospital Colorado) Program
For Patients:
My research interests are focused on identifying why some children with single ventricle heart disease do well with surgical palliation while others are prone to heart failure. Increasing our understanding of heart failure in this population is essential to improving outcomes for the future.
My research interests are focused on identifying why some children with single ventricle heart disease do well with surgical palliation while others are prone to heart failure. Increasing our understanding of heart failure in this population is essential to improving outcomes for the future.
For Referring Providers:
My research interests focus on elucidating the molecular mechanisms underlying pediatric single ventricle heart failure with the goal of discovering novel pediatric-specific therapeutic targets. Currently, my projects include: 1) determining the molecular and functional myocardial effects of phosphodiesterase 1 inhibition in the failing single ventricle, and 2) identifying circulating miRNAs that may represent biomarkers of single ventricle heart failure.
My research interests focus on elucidating the molecular mechanisms underlying pediatric single ventricle heart failure with the goal of discovering novel pediatric-specific therapeutic targets. Currently, my projects include: 1) determining the molecular and functional myocardial effects of phosphodiesterase 1 inhibition in the failing single ventricle, and 2) identifying circulating miRNAs that may represent biomarkers of single ventricle heart failure.
Austin Larson, MD
Clinical Genetics and Genomics - General, Medical Biochemical Genetics, Pediatrics
Taizo Nakano, MD
Hematology/Oncology - Pediatric, Pediatrics
Scott Auerbach, MD
Cardiology - Pediatric, Pediatrics
Stephanie Nakano, MD
Cardiology - Pediatric, Pediatrics
Cesar Gonzalez de Alba, MD
Cardiology - Pediatric, Pediatrics